IGC https://inflammationglobalcare.com/ inflammation global care Tue, 12 Mar 2024 14:24:24 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.1 https://inflammationglobalcare.com/wp-content/uploads/2023/07/‏‏logo-19-עותק-100x100.png IGC https://inflammationglobalcare.com/ 32 32 Can An Israeli Discovery Bring Relief To The Lives Of Patients Battling Inflammatory Diseases Worldwide? https://inflammationglobalcare.com/2023/10/18/can-an-israeli-discovery-bring-relief-to-the-lives-of-patients-battelings-inflammatory-diseases-worldwide/ https://inflammationglobalcare.com/2023/10/18/can-an-israeli-discovery-bring-relief-to-the-lives-of-patients-battelings-inflammatory-diseases-worldwide/#respond Wed, 18 Oct 2023 09:45:44 +0000 https://inflammationglobalcare.com/?p=1286 Can An Israeli Discovery Bring Relief To The Lives Of Patients Battling Inflammatory Diseases Worldwide? According to field reports, the answer is definitely YES! (See users’ testimonials below) https://youtu.be/IEog9n20w0w After gathering substantial evidence from patients whose lives have changed dramatically, the team at Amorphical is thrilled to announce a groundbreaking discovery that has brought considerable […]

The post Can An Israeli Discovery Bring Relief To The Lives Of Patients Battling Inflammatory Diseases Worldwide? appeared first on IGC.

]]>

Can An Israeli Discovery Bring Relief To The Lives Of Patients Battling Inflammatory Diseases Worldwide?

According to field reports, the answer is definitely YES! (See users' testimonials below)

After gathering substantial evidence from patients whose lives have changed dramatically, the team at Amorphical is thrilled to announce a groundbreaking discovery that has brought considerable relief to individuals suffering from Crohn’s disease, colitis, and other chronic inflammatory diseases.

The constant challenges faced by patients with inflammatory bowel diseases—frequent restroom visits, diarrhea, isolation, dietary restrictions, and the overall struggle to maintain a normal life—have always been at the forefront of our scientists’ minds. In response to these challenges, we have recently expanded our production capacity, enabling us to offer our innovative solution, PH Gastrilex, internationally for the first time beyond the borders of Israel. This remarkable development is specifically designed to provide relief and support for individuals experiencing the pain and discomfort associated with Crohn’s disease and colitis. Below, you will find testimonials from people whose lives have been significantly transformed by PH Gastrilex, alongside an explanation of the unique approaches that differentiate our product from any other on the market.

An area in the body inflamed with a gastrointestinal disease

An area in the body inflamed with a gastrointestinal disease

First: Why is this considered a scientific breakthrough? It is recognized as a scientific breakthrough because of their innovations related to anti-inflammatories, all hinging on the technology they pioneered. This technology paves a new path for patients. During their trials, they successfully replicated nature’s processes within the human body. This is a groundbreaking revolution, akin to the discovery of penicillin or the realization that ulcers result from bacteria. They address inflammations from an entirely fresh perspective, introducing an entirely new realm of science. To elaborate, currently, individuals consume various types of anti-inflammatory medications to treat chronic inflammations. These aren’t natural substances and often have adverse side effects, not to mention their dubious effectiveness (as you might have encountered). Their groundbreaking approach treats inflammation by mirroring the body’s natural mechanism employed to counter inflammatory reactions. For years, countless global institutions endeavored to perfect miniaturization technology, and this is where inflammation global care triumphed. This miniaturization technology enables the body to produce more bicarbonate (which it naturally uses against inflammation), reaching inflamed areas efficiently across all body cells. Their researchers succeeded in developing anti-inflammatory agents in the laboratory using natural minerals. Their core component is minuscule, 10 times smaller than a virus, adept at targeting the acidic extracellular environment and treating it, thus neutralizing inflammation.

A close-up view of a cell affected by Crohn’s disease

This miniaturization technology can target the extracellular acidic environment.
NASA isn’t the only entity intrigued by their work. Far from it!
Numerous investors from Israel and overseas have discerned the exceptional developments underway in the Desert, backing their ongoing research and development. They take pride in their remarkable partnerships with academic institutions and researchers in the US and Europe. Initially skeptical, the Company’s employees now operate with a profound sense of purpose, fully aware they’re part of a transformative scientific endeavor that could redefine inflammation managment. This technology is here for the long haul. Their recent double-blind study confirmed that their primary component is effective against Coronavirus with a 100% success rate. Additionally, in collaboration with NASA, they demonstrated their pioneering patent’s capability to foster bone and muscle cell growth.

They are confident in their breakthrough.

A close-up view of a cell affected by Crohn’s disease

Numerous forward-thinking mainstream physicians have incorporated their product, PH Gastrilex, driven by the desire to stay updated. They’ve received testimonials from many inflammatory bowel disease patients, previously let down by traditional medicine, who then experimented with PH Gastrilex upon their doctor’s advice. The results were positive.

Q&A

Choosing PH Gastrilex means embracing a solution that stands at the forefront of health innovation. It is not merely about managing symptoms but fundamentally altering the inflammatory landscape for lasting relief. This product not only neutralizes inflammation but also supports tissue repair, balancing the body’s pH levels with essential minerals for comprehensive healing.

Key Features:

  • Precision Delivery: Utilizes cutting-edge technology for the targeted release of amorphous nano minerals, directly addressing areas of chronic inflammation.
  • Controlled Release: Amorphous nano minerals are meticulously engineered to adjust acidity levels, promoting the restoration of affected tissues.
  • Scientifically Backed: Supported by 130 patents, PH Gastrilex is the culmination of rigorous research and dedication to scientific excellence.
  • Natural Mechanism: Inspired by the body’s production of bicarbonate for acidity regulation, offering a natural solution to bolster the body’s defense against inflammation.
  • Innovative Approach: With 78% of users reporting noticeable improvements, PH Gastrilex provides a promising alternative to traditional methods, emphasizing safety and long-term well-being.
  • Inspiration from Nature: Developed from nano-amorphous technology, mirroring the regenerative abilities of the blue crayfish, allowing for comprehensive cellular reach and healing.

PH Gastrilex is beneficial for individuals with Crohn’s and colitis because it embodies a novel approach to inflammation, a critical challenge in medicine. With 78% of our clients reporting noticeable improvements within the first few weeks, it offers a promising alternative to traditional treatments.

Our breakthrough utilizes nano-amorphous technology inspired by the unique capabilities of the blue crayfish studied by researchers at Ben Gurion University. This technology allows for the creation of amorphous minerals, which are significantly smaller than crystalline elements and can reach and nourish every cell, effectively targeting and treating inflamed areas. Unlike traditional treatments that can be harmful over the long term, PH Gastrilex is designed for safe, prolonged use.

The product works by adjusting the body’s pH levels at inflammation sites and delivering essential minerals needed for tissue repair. This “hybrid solution” not only neutralizes inflammation but also promotes healing in a balanced and comprehensive manner. It’s a revolutionary method that offers a more natural and potent approach to managing inflammatory bowel diseases.

By choosing PH Gastrilex, you are opting for a scientifically backed, patented formula that has been synthesized, stabilized, and preserved in collaboration with leading experts. This global solution empowers you to regain control over your health and could be the key to a life free from the discomfort of chronic inflammation.

Is PH Gastrilex right for you? Given its success with thousands of users, we encourage you to try it and experience its benefits firsthand.

The effectiveness of PH Gastrilex is substantiated by a solid foundation of research and clinical study outcomes. To delve into the specifics, we invite you to visit our repository of scientific articles and findings at:

 

These resources include detailed discussions on the science behind our innovation and its application in the management of inflammatory conditions.

The efficacy of PH Gastrilex is not only supported by extensive research and clinical studies but also by real-life applications within Israel. Serving as a living laboratory, Israel offers proof of concept for inflammation management with PH Gastrilex, evidencing life-changing improvements in individuals dealing with chronic inflammation. Tens of thousands have incorporated Amorphical products into their daily regimen, finding relief from conditions such as chronic inflammation, osteoporosis, sports injuries, Crohn’s, and colitis. Their collective experience underlines the product’s ability to significantly enhance the quality of life. This stands in stark contrast to the long-term risks often associated with conventional medications. The recent approval of PH Gastrilex by the Israeli ministry of health(MOH) is a testament to its safety and potential in effectively managing chronic inflammatory conditions.

Yes, the company’s products have undergone rigorous laboratory testing to ensure high product safety standards (ISO9001, HACCP regulations) and are approved by the Israeli Ministry of Health’s GMP (Good Manufacturing Practice) certification. IGC aims to provide its customers with high-quality, safe, and effective nutritional innovations.

Recommended Usage of PH Gastrilex Based on User Experiences

Approach A (Gradual Increase):

For most users, we recommend starting with Approach A.

  • Week 1: Begin with 4 capsules daily.
  • Week 2: If you notice improvements, continue with 6 capsules daily for the next two weeks. If not, increase to 8 capsules.
  • Week 3 or 4: Depending on your response:
    • If improved: Stick with 6 capsules for another two weeks.
    • If no improvement: Increase to 8 capsules daily.
  • Beyond Week 4: If you’re taking 8 capsules, continue for two more weeks.

After one month, step down to 6 capsules for two weeks, and then to 4 capsules as a maintenance dose.

 

After about one and a half months, once improvements are stable, maintain a dose of 4 capsules daily for ongoing support.

 

Approach B (Immediate Higher Dose for Active Inflammation):

First Month: For addressing active inflammation, begin with 8 capsules daily. Distribute the dosage as follows: 3 capsules in the morning, 2 in the afternoon, and 3 in the evening.

Second Month: After observing symptom relief, reduce the intake to 6 capsules daily. Continue this dosage for the entire month to consolidate the improvements.

Subsequent Period: Transition to a maintenance dose of 4 capsules per day for ongoing support.

 

In both approaches, it’s crucial to observe your body’s reactions and adjust the dosage as needed.

Each bottle contains 60 capsules.

If you follow Approach A, which recommends starting with 4 capsules daily for the first two weeks and then increasing to 6 capsules for the next two weeks before reverting to 4 capsules regularly, you’ll need more than two bottles in the first month. To determine if this product is suitable for you, a two-month trial is suggested.

For severe flare-ups, starting with 8 capsules a day is necessary, which would require almost two bottles within the first two weeks alone. Therefore, we recommend purchasing a four-bottle bundle initially.

The maintenance dosage is 4 capsules per day to manage inflammation, so even if you only take 4 a day, it’s beneficial to purchase at least 4 bottles.

Capsule Intake Instructions:
Maintain an interval of one hour between consuming PH Gastrilex capsules and eating food or taking other medications/substances. This helps ensure optimal absorption and effectiveness of the capsules

When PH Gastrilex interacts with the inflamed area, it may produce gas and bloating. This typically occurs within the first one to three weeks. The discomfort is an indication that PH Gastrilex is active in the body. At any stage, you can consult your family doctor or contact us with any questions.

Store the product in a cool, dry, and shaded place. Do not refrigerate. Do not leave it in a closed car or exposed to direct sunlight.

As with many users who have experienced positive effects from the product, it is recommended to ensure continuity. Based on our experience, placing your next order with a three-week buffer is advised to maintain consistent usage.

The product is a nutritional solution and does not require a prescription. Pregnant and nursing women, individuals taking prescription medication, and children should consult with a physician before use. Additionally, individuals with hypercalcemia, hyperphosphatemia, or hypercalciuria should not use the product.

Yes, IGC provides a refund policy for unopened packages. If you are dissatisfied with the product or if it does not meet your expectations, you can contact our customer support within the designated timeframe to request a refund. Please note that this policy applies to unopened packages, and only applies to the first order. please be aware that certain terms and conditions may apply. Our customer support team will be glad to assist you with any questions or concerns regarding the refund process.

For additional details, please refer to our refund policy page.

PH Gastrilex

Approved by Israel’s Ministry of Health, this 96% pure ACC, preservative-free product uses nano-amorphous technology. Research has found that its slow-release mechanism balances pH at inflammation sites and enhances mineral absorption, aiding in recovery. PH Gastrilex has a 90% satisfaction rate among our customers who suffer from Crohn’s disease

Patient testimonials

“After two weeks on PH Gastrilex I started normal functioning. I started eating things I didn’t dare touch for years”. Rona, Author of Romantic Novels, battling Crohn’s disease.

Rona Sharon, Battling Crohn’s and Other Gastrointestinal Diseases

“I feel completely normal – it’s a miracle. I function normally and eat normally.” Oded Levy, battling Crohn’s disease.

Oded Levy, Battling Crohn’s Disease

“I tried everything and still suffered from excruciating pain.” Oded Levy, Director of Construction, battling Crohn’s disease.

Ohad, Battling Crohn’s Disease

“PH Gastrilex gave me back control over my life.” Kochi Manovella, Battling Crohn’s Disease”

 Kochi Manovella, Battling Crohn’s Disease

Have a question? contact us below

The post Can An Israeli Discovery Bring Relief To The Lives Of Patients Battling Inflammatory Diseases Worldwide? appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/10/18/can-an-israeli-discovery-bring-relief-to-the-lives-of-patients-battelings-inflammatory-diseases-worldwide/feed/ 0
The impact of the components of PH Gastrilex on cancer prevention as reported in the magazine ‘Cancers’ https://inflammationglobalcare.com/2024/02/20/the-impact-of-the-components-of-ph-gastrilex-on-cancer-prevention-as-reported-in-the-magazine-cancers/ https://inflammationglobalcare.com/2024/02/20/the-impact-of-the-components-of-ph-gastrilex-on-cancer-prevention-as-reported-in-the-magazine-cancers/#respond Tue, 20 Feb 2024 11:16:02 +0000 https://inflammationglobalcare.com/?p=3787 The impact of the components of PH Gastrilex on cancer prevention as reported in the magazine ‘Cancers’ ACC not only shows promise in killing cancer

The post The impact of the components of PH Gastrilex on cancer prevention as reported in the magazine ‘Cancers’ appeared first on IGC.

]]>

The impact of the components of PH Gastrilex on cancer prevention as reported in the magazine 'Cancers'

ACC not only shows promise in killing cancer cells but also plays a critical role in neutralizing chronic inflammation, a common trait in conditions like Crohn’s and colitis. This dual-action approach indicates that ACC could significantly reduce inflammation, thereby preventing the environment that fosters cancer development. For individuals suffering from chronic inflammatory diseases, ACC offers a beacon of hope by potentially diminishing the severity of their condition and lowering their risk of cancer progression. This highlights ACC’s unique capability to attack the root cause of inflammation-related cancers, providing a preventative and therapeutic advantage.

The post The impact of the components of PH Gastrilex on cancer prevention as reported in the magazine ‘Cancers’ appeared first on IGC.

]]>
https://inflammationglobalcare.com/2024/02/20/the-impact-of-the-components-of-ph-gastrilex-on-cancer-prevention-as-reported-in-the-magazine-cancers/feed/ 0
What Are The Side Diseases Crohn’s Illness Might Bring With It? https://inflammationglobalcare.com/2024/02/01/what-are-the-side-diseases-crohns-illness-might-bring-with-it/ https://inflammationglobalcare.com/2024/02/01/what-are-the-side-diseases-crohns-illness-might-bring-with-it/#respond Thu, 01 Feb 2024 11:10:40 +0000 https://inflammationglobalcare.com/?p=3238 What Are The Side Diseases Crohn’s Illness Might Bring With It? Crohn’s disease, an inflammatory bowel disease, is known for its relentless attacks on the

The post What Are The Side Diseases Crohn’s Illness Might Bring With It? appeared first on IGC.

]]>

What Are The Side Diseases Crohn's Illness Might Bring With It?

Crohn’s disease, an inflammatory bowel disease, is known for its relentless attacks on the digestive tract, causing inflammation, pain, and other uncomfortable symptoms. But, the impact of Crohn’s disease goes beyond the digestive system. It is essential to understand the potential side diseases and conditions that may accompany Crohn’s to better manage overall health. Several studies have confirmed the association between Crohn’s disease and various conditions. Here, we will discuss these side diseases and delve into the research that confirms their connection.

1. Arthritis
One of the most common extraintestinal complications of Crohn’s disease is arthritis. Research shows that nearly 25% of people with Crohn’s also develop arthritis, which causes joint pain and stiffness. A study published in Clinical and Experimental Gastroenterology in 2011 confirms that arthritis is more prevalent among Crohn’s patients compared to the general population. Arthritis in Crohn’s patients is often most prominent in the large joints of the lower extremities and can significantly impair mobility.

Arthritis in large joints of the lower extremities

Arthritis in large joints of the lower extremities

2. Osteoporosis
Long-term inflammation, along with certain medications used to manage Crohn’s, can lead to loss of bone density and osteoporosis. The National Institute of Arthritis and Musculoskeletal and Skin Diseases highlights that people with inflammatory bowel disease, including Crohn’s, are at increased risk of osteoporosis. As bone density decreases, the risk for fractures increases, even from minor injuries or falls.

3. Skin Conditions
Skin conditions such as Erythema nodosum and Pyoderma gangrenosum are more common in individuals with Crohn’s disease. A review in the World Journal of Gastroenterology in 2015 elaborated on how Crohn’s disease could manifest through various skin conditions, which affects about 20-44% of patients. Erythema nodosum presents as tender, red nodules, usually on the shins, whereas Pyoderma gangrenosum is characterized by painful ulcers.

Blood clots in the circulatory system as a complication
associated with Crohns disease

4. Eye Disorders
Crohn’s disease may cause eye problems, including uveitis (inflammation of the middle layer of the eye) and episcleritis (inflammation of the whites of the eyes). A 2015 study published in The American Journal of Medicine found that people with Crohn’s disease have an increased risk of developing these eye conditions. These conditions can cause redness, pain, blurred vision, and sensitivity to light. Prompt treatment is essential to prevent long-term damage.

5. Nutritional Deficiencies
The inflammation in the intestines associated with Crohn’s disease can affect the absorption of nutrients. This leads to malnutrition and vitamin and mineral deficiencies. A study in the Journal of Clinical Gastroenterology in 2009 showed that vitamin D deficiency is especially common in Crohn’s patients. Vitamin D is crucial for bone health, and its deficiency can exacerbate the risk of osteoporosis.

Blood clots in the circulatory system as a complication
associated with Crohns disease

6. Mental Health Issues
People with Crohn’s disease are more likely to experience mental health issues such as anxiety and depression. The emotional strain of dealing with a chronic illness can exacerbate these conditions. A meta-analysis published in the Journal of Psychosomatic Research in 2017 confirmed that there is a higher prevalence of anxiety and depression among patients with Crohn’s disease. Addressing mental health is a critical component of the holistic treatment approach for Crohn’s disease.

7. Increased Risk of Blood Clots
Patients with Crohn’s disease are at a higher risk of developing blood clots, including deep vein thrombosis. According to research published in Inflammatory Bowel Diseases journal in 2010, patients with inflammatory bowel disease, including Crohn’s, have a two to three times higher risk of thromboembolism. Blood clots can be dangerous as they can travel to the lungs, causing a potentially life-threatening pulmonary embolism.

A Holistic Approach: Combining the Traffic Light Method with Ph Gastrilax

To effectively manage Crohn’s disease and its associated conditions, it’s essential to consider a comprehensive treatment plan. Two innovative approaches, the Traffic Light Method and Ph Gastrilax, can be combined for this purpose.

The Traffic Light Method, developed by Adi Zusman, focuses on a gradual dietary approach to treat bowel diseases. It is based on recognizing the body’s signals and restoring balance through diet and lifestyle changes.

Ph Gastrilax, a groundbreaking technology by Amorphical, uses natural minerals in ultra-fine particles to combat inflammation by mimicking the body’s anti-inflammatory mechanisms.

Together, these methodologies offer a synergistic and holistic treatment plan for Crohn’s disease, targeting both dietary balance and inflammation control. By combining nutrition, lifestyle changes, and targeted anti-inflammatory treatment, individuals can work towards optimal well-being and effective management of Crohn’s disease and its side diseases.

Illustrative image showing a transparent human body
with highlighted inflamed areas

Illustrative image showing a transparent human body
with highlighted inflamed areas

PH Gastrilex

Approved by Israel’s Ministry of Health, this 96% pure ACC, preservative-free product uses nano-amorphous technology. Research has found that its slow-release mechanism balances pH at inflammation sites and enhances mineral absorption, aiding in recovery. PH Gastrilex has a 90% satisfaction rate among our customers who suffer from Crohn’s disease

Patient testimonials

“After two weeks on PH Gastrilex I started normal functioning. I started eating things I didn’t dare touch for years”. Rona, Author of Romantic Novels, battling Crohn’s disease.

Rona Sharon, Battling Crohn’s and Other Gastrointestinal Diseases

“I feel completely normal – it’s a miracle. I function normally and eat normally.” Oded Levy, battling Crohn’s disease.

Oded Levy, Battling Crohn’s Disease

“I tried everything and still suffered from excruciating pain.” Oded Levy, Director of Construction, battling Crohn’s disease.

Ohad, Battling Crohn’s Disease

“PH Gastrilex gave me back control over my life.” Kochi Manovella, Battling Crohn’s Disease”

 Kochi Manovella, Battling Crohn’s Disease

The post What Are The Side Diseases Crohn’s Illness Might Bring With It? appeared first on IGC.

]]>
https://inflammationglobalcare.com/2024/02/01/what-are-the-side-diseases-crohns-illness-might-bring-with-it/feed/ 0
American Astronaut’s Visit to Israel https://inflammationglobalcare.com/2023/11/21/american-astronauts-visit-to-israel/ https://inflammationglobalcare.com/2023/11/21/american-astronauts-visit-to-israel/#respond Tue, 21 Nov 2023 14:21:59 +0000 https://inflammationglobalcare.com/?p=1657 AMERICAN ASTRONAUT’S VISIT TO ISRAEL American Astronaut’s Visit To The Israeli Desert: Exploring The Potential Of An Innovative Substance For Space Health In September 2020,

The post American Astronaut’s Visit to Israel appeared first on IGC.

]]>

AMERICAN ASTRONAUT'S VISIT TO ISRAEL

American Astronaut's Visit To The Israeli Desert:
Exploring The Potential Of An Innovative Substance For Space Health

In September 2020, Two American Astronauts Visited the Plant And Laboratories in south Israel To Learn About The Incredible Potential the new technology, Developed By Amorphical in collaboration with the inflammation global care.

This Revolutionary Compound Has Gained Attention For Its Unique Properties That Could Benefit Space Exploration And Human Health. The Visit Aimed To Uncover The Transformative Power Of the substance And Address The Challenges Astronauts Face During Space Missions. Let’s Dive Into Their Visit.

DISCOVERING THE POWER OF ACC:

During Their Visit, The American Astronauts Witnessed Firsthand The Remarkable Properties And Applications Of Amorphous Calcium. They Learned About The Scientific Processes Used To Create And Stabilize This Compound, Which Plays A Crucial Role In Addressing Bone Health Challenges During Space Travel. Additionally, They Were Introduced To The Potential Of Amorphous Calcium In Managing Inflammation.

Areas commonly affected by bone density loss and weakness
in astronauts, such as the spine, hips, and long bones
Areas commonly affected by bone density loss and weakness
in astronauts, such as the spine, hips, and long bones

INFLAMMATORY CHALLENGES IN SPACE:

Space Travel Presents Unique Challenges, Including Increased Inflammation Caused By The Microgravity Environment And Changes In The Body. Prolonged Exposure To Microgravity Leads To Bone And Muscle Loss, Weakened Immune Systems, And Altered Metabolic Functions, All Contributing To Higher Inflammation Levels And Risks Of Inflammatory Diseases.

THE 2018 SPACE EXPERIMENT AND PROMISING RESULTS:

In A Notable Space Experiment Conducted In 2018, ACC Was Sent To Space To Study Its Effects On Bone Cell Development And Tissue Formation. The Experiment Demonstrated That ACC Supplementation Facilitated The Growth And Alignment Of Bone-Building Cells, Leading To The Creation Of Real Bone Tissue In Space. These Findings Opened Up Exciting Possibilities For Using ACC To Counteract Bone And Muscle Loss, As Well As To Reduce Inflammation In Astronauts During Extended Space Missions.

A close-up view of a cell affected by Crohn’s disease

THE POTENTIAL OF AMORPHOUS CALCIUM IN INFLAMMATION CONTROL:

Amorphous Calcium Carbonate (ACC) Has Shown Promise In Mitigating The Inflammatory Processes Triggered By Space Travel. Studies Suggest That ACC Possesses Anti-Inflammatory Properties, Which Can Help Reduce Inflammation And Its Negative Effects. By Supplementing Astronauts With ACC, Scientists Believe It Can Regulate Immune Responses, Modulate Inflammatory Pathways, And Promote Tissue Repair And Regeneration, Thereby Reducing The Risk Of Inflammatory Diseases.

CONTRIBUTIONS TO OTHER INFLAMMATORY DISEASES:

Beyond Its Potential Benefits For Space Health, Amorphous Calcium Carbonate Has Also Shown Promise In Managing Other Inflammatory Diseases Like Crohn’s Disease. At The Moment, Two Clinical Experiments With Crohn’s Disease Are Taking Place, And Many Patients Have Shown Significant Relief And Achieved Remission. By Targeting The Underlying Inflammatory Processes, ACC Offers New Possibilities For Improving The Quality Of Life For Patients With Inflammatory Diseases.

A close-up view of of bone-building cells

The Visit By American Astronauts To The innovative Manufacturing Plant And Laboratories In September 2020 Unveiled The Remarkable Potential Of Amorphous Calcium For Space Health. Through Firsthand Experiences, Discussions, And The Groundbreaking Space Experiment In 2018, The Astronauts Witnessed The Unique Properties Of Amorphous Calcium And Its Potential In Reducing Inflammation During Space Missions.

Additionally, ACC’s Contribution To Managing Other Inflammatory Diseases Like Crohn’s, With Ongoing Clinical Experiments Showcasing Promising Results, Highlights Its Versatility And Impact In The Field Of Healthcare. As IGC Continues Its Research And Exploration, This Visit Exemplifies The Ongoing Collaboration Between Space Agencies And Innovative Companies, Shaping The Future Of Human Health And Space Exploration Based On The Transformative Potential Of Amorphous Calcium.

The post American Astronaut’s Visit to Israel appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/11/21/american-astronauts-visit-to-israel/feed/ 0
COVID-19 and Inflammatory Diseases https://inflammationglobalcare.com/2023/11/21/covid-19-and-inflammatory-diseases/ https://inflammationglobalcare.com/2023/11/21/covid-19-and-inflammatory-diseases/#respond Tue, 21 Nov 2023 14:09:07 +0000 https://inflammationglobalcare.com/?p=1650 COVID-19 and Inflammatory Diseases You might wonder, “Is there a link between the coronavirus and the challenges of chronic inflammation?” Both conditions, though distinct, center

The post COVID-19 and Inflammatory Diseases appeared first on IGC.

]]>

COVID-19 and Inflammatory Diseases

You might wonder, “Is there a link between the coronavirus and the challenges of chronic inflammation?” Both conditions, though distinct, center around infection. COVID-19 arises from the SARS-CoV-2 virus, while chronic inflammation is believed to be influenced by certain infections. Given this connection, we are eager to highlight the insights ACC offers in addressing various infections, including the pervasive coronavirus.

Exploring the Potential Link Between COVID-19 and Inflammatory Diseases: Success of AMOR18 Clinical Trial for Corona Patients.
AMOR18, a significant component also found in PH Gastrilex, has shown promising results in clinical trials for treating COVID-19 patients. This key ingredient, shared by both AMOR18 and Gastrilex, represents a notable breakthrough in addressing both the coronavirus and inflammatory diseases.

The outbreak of COVID-19 has not only posed significant challenges to public health but has also shed light on the connection between the virus and inflammatory diseases. COVID-19, caused by the SARS-CoV-2 virus, has been associated with various inflammatory conditions, such as pneumonia and acute respiratory distress syndrome (ARDS). Understanding and addressing the inflammatory response triggered by the virus is crucial in developing effective treatments. In this context, Dr. Nashat Abu Salah, Director of the Corona Department and Director of the Geriatrics Department at Ziv Medical Center in Safed, shares insights on the success of the clinical trial for a potential cure for corona patients.

The trial utilized the new drug AMOR18, developed in Israel in collaboration with the inflammation global care, which showed promising results in treating COVID-19 patients. Administered through inhalation and as a powder under the tongue, this unique medication containing amorphous calcium carbonate as the active substance has demonstrated a remarkable 100% success rate, leading to swift recovery and subsequent discharge of patients. These encouraging outcomes bring hope not only to the corona patients in Israel but also to the broader field of medicine worldwide.

COVID 19

COVID 19

Dr. Nashat also explained phase 2 of the clinical trial: In the double-blind trial, 50% of the patients received the new drug AMOR-18 and the remaining 50% received a placebo (dummy drug). A total of 37 patients in a moderate-severe condition participated. Of these, 18 patients were treated with the new drug AMOR-18, recovered, and were discharged home within a few days. The other 19 patients were treated with a placebo, of whom 6 were transferred to the Intensive Care Unit and 2 unfortunately succumbed to the disease.

So far, 58 patients have volunteered for the trial, and these days the clinical trial continues in medical centers such as Ziv, Shamir, Kaplan, and Ma’eini Hashuah. The research is expected to expand in the coming weeks to a hospital in Brazil, where the experiment will be conducted on COVID-19 infected individuals.

The drug, given by inhalation and as a powder under the tongue, raises the pH level in the body, halting the deterioration process in severe COVID-19 patients and activating the immune system until recovery. Amorphical’s amorphous calcium carbonate stands as the unique development in this medicine.

A zoom in image of Amorphous Calcium Carbonate
(ACC) with its unique, and non-crystalline form

A zoom in image of Amorphous Calcium Carbonate
(ACC) with its unique, and non-crystalline form

The post COVID-19 and Inflammatory Diseases appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/11/21/covid-19-and-inflammatory-diseases/feed/ 0
Great Results in Space: NASA’s Experiment with Amorphical https://inflammationglobalcare.com/2023/11/21/great-results-in-space-nasas-experiment-with-amorphical/ https://inflammationglobalcare.com/2023/11/21/great-results-in-space-nasas-experiment-with-amorphical/#respond Tue, 21 Nov 2023 13:49:20 +0000 https://inflammationglobalcare.com/?p=1635 Great Results in Space: NASA’s Experiment in Israel NASA’s Experiment With Israeli Scientists On The Effects of a New Groundbreaking Substance Dive into the article

The post Great Results in Space: NASA’s Experiment with Amorphical appeared first on IGC.

]]>

Great Results in Space: NASA's Experiment in Israel

NASA's Experiment With Israeli Scientists On The Effects of a New Groundbreaking Substance

Dive into the article to understand how this breakthrough could reshape
your live and the lives of all those battling Crohn’s disease

NASA’s Experiment With Israeli Scientists On The Effects Of Amorphous Calcium Carbonate In Human Bone, Muscle Cell Growth, And Potential Implications For Inflammatory Diseases.

Our collaboration with NASA was made to Conduct Three Space Experiments Involving Human Bone and Muscle Cells. The Results Indicate Notable Findings. These Studies Tested The Growth Of Essential Cells With One Group Being Exposed To the substance, While A Second Group Served As A Control Without The Substance. The Data Shows That In All Three Experiments, Amorphous Calcium Carbonate (ACC) Was Effective In Promoting The Growth Of Bone And Muscle Cells.

This Discovery Could Have Implications In Both Medicine And Space Research. The Technology Behind These Amorphous Nano-Minerals Continues To Evolve. It Remains To Be Seen What Developments The Future Holds For The Collaboration Between inflammation global care And NASA

A Formal Scientific Article Will Be Published Soon With The Results Of The Experiments

A Formal Scientific Article Will Be Published Soon With The Results Of The Experiments

The post Great Results in Space: NASA’s Experiment with Amorphical appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/11/21/great-results-in-space-nasas-experiment-with-amorphical/feed/ 0
Amorphous Calcium Carbonate Boosts Women’s Exercise Performance https://inflammationglobalcare.com/2023/07/11/amorphous-calcium-carbonate-boosts-womens-exercise-performance/ https://inflammationglobalcare.com/2023/07/11/amorphous-calcium-carbonate-boosts-womens-exercise-performance/#respond Tue, 11 Jul 2023 10:55:08 +0000 https://inflammationglobalcare.com/?p=811 Amorphous Calcium Carbonate Boosts Women’s Exercise Performance The study tested the effects of 9 weeks of amorphous calcium carbonate (ACC) supplementation (1000 mg/day) and resistance

The post Amorphous Calcium Carbonate Boosts Women’s Exercise Performance appeared first on IGC.

]]>

Amorphous Calcium Carbonate Boosts Women's Exercise Performance

The study tested the effects of 9 weeks of amorphous calcium carbonate (ACC) supplementation (1000 mg/day) and resistance exercise training on one repetition maximum (1-RM) values. The participants significantly improved their mean back squat and bench press 1-RM values, and the ACC group had higher post-pre bench press 1-RM differences compared to the placebo group. No significant difference was observed in the bench press 1-RM values between the groups. The study suggests that ACC supplementation can augment the improvement of maximum amount generated force during resistance training.

The post Amorphous Calcium Carbonate Boosts Women’s Exercise Performance appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/07/11/amorphous-calcium-carbonate-boosts-womens-exercise-performance/feed/ 0
Crustacean Shells https://inflammationglobalcare.com/2023/07/11/crustacean-shells-a-breakthrough-in-calcium-supplements/ https://inflammationglobalcare.com/2023/07/11/crustacean-shells-a-breakthrough-in-calcium-supplements/#respond Tue, 11 Jul 2023 10:37:37 +0000 https://inflammationglobalcare.com/?p=779 Crustacean Shells: A Breakthrough in Calcium Supplements provides better absorption Israeli researchers created a technology that stabilizes an unstable form of calcium carbonate. This stabilized

The post Crustacean Shells appeared first on IGC.

]]>

Crustacean Shells:

A Breakthrough in Calcium Supplements provides better absorption

Israeli researchers created a technology that stabilizes an unstable form of calcium carbonate. This stabilized mineral provides better absorption and retention rates compared to other sources used for dietary calcium supplements.

Common mineral deficiencies in Crohn’s disease encompass a variety of essential minerals that are critical for the body’s overall health and well-being. Crohn’s disease often affects the small intestine, which is where most minerals are absorbed, and this can result in decreased absorption and subsequent deficiencies.

The post Crustacean Shells appeared first on IGC.

]]>
https://inflammationglobalcare.com/2023/07/11/crustacean-shells-a-breakthrough-in-calcium-supplements/feed/ 0